Synapses as therapeutic targets for autism spectrum disorders: An international symposium held in pavia on July 4th, 2014

Frontiers in Cellular Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Curatolo, Paolo ^a   Ben Ari, Yehezkel ^b   Bozzi, Yuri ^c   Catania, Maria Vincenza ^d,e   D’Angelo, Egidio ^f,g   Mapelli, Lisa ^f   Oberman, Lindsay M ^h   Rosenmund, Christian ⁱ   Cherubini, Enrico ^j,k  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INSERM   (France)

^c UNIVERSITY OF TRENTO   (Italy)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^e OASI RESEARCH INSTITUTE IRCCS   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^h BROWN UNIVERSITY   (United States)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j SISSA   (Italy)

^k EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

more..

Author keywords

Animal models; ASDs; GABAergic signaling; Synapse; Therapeutic target

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CHROMOSOME22; DOUBLECORTIN; FRAGILE X MENTAL RETARDATION PROTEIN; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; METABOTROPIC RECEPTOR 5; METHYL CPG BINDING PROTEIN 2; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLIGIN; PARVALBUMIN; PROTEIN HOMER; RAPAMYCIN; RNA BINDING PROTEIN; TUBERIN; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; CHROMOSOME DELETION 22Q11; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONGENITAL MALFORMATION; EPILEPSY; EVOKED MUSCLE RESPONSE; FRAGILE X SYNDROME; GABAERGIC TRANSMISSION; GENE MUTATION; GENE SILENCING; HAPLOINSUFFICIENCY; HAPPY PUPPET SYNDROME; HUMAN; INFANTILE SPASM; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NEUROFIBROMATOSIS; NONHUMAN; PHENOTYPE; PROTEIN SYNTHESIS; PURKINJE CELL; RETT SYNDROME; RNA METABOLISM; SYNAPSE; SYNAPTIC DYSFUNCTION; SYNAPTIC SIGNALING; TRANSCRANIAL MAGNETIC STIMULATION; TUBEROUS SCLEROSIS; X CHROMOSOMAL INHERITANCE;

EID: 84907521823     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00309     Document Type: Article

References (31)

1. Benali, A., Trippe, J., Weiler, E., Mix, A., Petrasch-Parwez, E., Girzalsky, W., et al. (2011). Theta-burst transcranial magnetic stimulation alters cortical inhibition. J. Neurosci. 31, 1193–1203. doi:10.1523/JNEUROSCI.1379-10.2011
2. Ben-Ari, Y.(2008). Neuro-archaeology:pre-symptomatic architecture and signature of neurological disorders. Trends Neurosci. 31, 626–636. doi:10.1016/j.tins.2008.09.002
3. Ben-Ari, Y., Khalilov, I., Kahle, K. T., and Cherubini, E. (2012). The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neurosci-entist. 18, 467–486. doi:10.1177/1073858412438697
4. Ben-Ari, Y., and Spitzer, N. C. (2010). Phenotypic checkpoints regulate neuronal development. Trends Neurosci. 33, 485–492. doi:10.1016/j.tins.2010.08.005
5. Benvenuto, A., Moavero, R., Alessandrelli, R., Manzi, B., and Curatolo, P. (2009). Syn-dromic autism: causes and pathological pathways. World J. Paediatr. 5, 169–176. doi:10.1007/s12519-009-0033-2
6. Brielmaier, J., Matteson, P. G., Silverman, J. L., Senerth, J. M., Kelly, S., Genes-tine, M., et al. (2012). Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS ONE 7:e40914. doi:10.1371/journal.pone.0040914
7. Casanova, M. F. (2006). Neuropathological and genetic findings in autism: the significance of a putative mini columnopathy. Neuroscientist. 12, 435–441. doi:10.1177/1073858406290375
8. Cellot, G., and Cherubini, E. (2014). Reduced inhibitory gate in the barrel cortex of neuroligin3 R451C knock-in mice, an animal model of autism spectrum disorders. Physiol. Rep. 2, e12070. doi:10.14814/phy2.12077
9. Chao, H. T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., et al. (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263–269. doi:10.1038/nature09582
10. Chao, H. T., Zoghbi, H. Y., and Rosenmund, C. (2007). MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65. doi:10.1016/j.neuron.2007.08.018
11. Curatolo, P., Napolioni, V., and Moavero, R. (2010). Autism spectrum disorders in tuberous sclerosis: pathogenic pathways and implications for treatment. J. Child Neurol. 25, 873–880. doi:10.1177/0883073810361789
12. D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nico-letti, F., et al. (2014). Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with intellectual disability and autism. Neurosci. Biobehav. Rev. doi:10.1016/j.neubiorev.2014.02.003
13. Földy, C., Malenka, R. C., and Südhof, T. C. (2013). Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 78, 498–509. doi:10.1016/j.neuron.2013.02.036
14. Geschwind, D. H., and Levitt, P. (2007). Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17, 103–111. doi:10.1016/j.conb.2007.01.009
15. Giuffrida, R., Musumeci, S., D’Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B.A., et al.(2005).Areducednumberofmetabotropicglutamate subtype 5 receptors are associated with constitutive Homer proteins in a mouse model of fragile X syndrome. J. Neurosci. 25, 8908–8916. doi:10.1523/JNEUROSCI.0932-05.2005
16. Giza, J., Urbanski, M. J., Prestori, F., Bandyopadhyay, B., Yam, A., Friedrich, V., et al. (2010). Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2. J. Neurosci. 30, 14805–14816. doi:10.1523/JNEUROSCI.1161-10.2010
17. Huang, Y. Z., Rothwell, J. C., Lu, C. S., Chuang, W. L., Lin, W. Y., and Chen, R. S. (2010). Reversal of plasticity-like effects in the human motor cortex. J. Physiol. 588, 3683–3693. doi:10.1113/jphysiol.2010.191361
18. Lemonnier, E., Degrez, C., Phelep, M., Tyzio, R., Josse, F., Grandgeorge, M., et al. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Transl. Psychiatry 2, e202. doi:10.1038/tp.2012.124
19. Lintas, C., and Persico, A. M. (2009). Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J. Med. Genet. 46, 1–8. doi:10.1136/jmg.2008.060871
20. Oberman, L., Eldaief, M., Fecteau, S., Ifert-Miller, F., Tormos, J. M., and Pascual-Leone, A. (2012). Abnormal modulation of corticospinal excitability in adults with Asperger’s syndrome. Eur. J. Neurosci. 36, 2782–2788. doi:10.1111/j.1460-9568.2012.08172.x
21. Oberman, L., Ifert-Miller, F., Najib, U., Bashir, S., Woollacott, I., Gonzalez-Heydrich, J., et al. (2010). Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile X syndrome and autism spectrum disorder. Front. Synaptic Neurosci. 2:26. doi:10.3389/fnsyn.2010.00026
22. Oberman, L. M., Rotenberg, A., and Pascual-Leone, A. (2013). Use of transcranial magnetic stimulationinautism spectrum disorders.J. AutismDev. Disord. [Epub ahead or print].
23. Provenzano, G., Pangrazzi, L., Poli, A., Sgadò, P., Genovesi, S., Zunino, G., et al. (2014). Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knockout mice. J. Neu-rosci. (in press).
24. Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N. P., Guo, W., Birnbaum, S. G., et al. (2012). Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 15, 431–440. doi:10.1038/nn.3033
25. Sato, A., Kasai, S., Kobayashi, T., Takamatsu, Y., Hino, O., Ikeda, K., et al. (2012). Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat. Commun. 3, 1292. doi:10.1038/ncomms2295
26. Sgadò, P., Genovesi, S., Kalinovsky, A., Zunino, G., Macchi, F., Allegra, M., et al. (2013a). Loss of GABAergic neurons in the hippocampus and cerebral cortex of engrailed-2 null mutant mice: implications for autism spectrum disorders. Exp. Neurol. 247, 496–505. doi:10.1016/j.expneurol.2013.01.021
27. Sgadò, P., Provenzano, G., Dassi, E., Adami, V., Zunino, G., Genovesi, S., et al. (2013b). Transcriptome profiling in engrailed2 knockout mice reveals common molecular pathways associated with ASD. Mol. Autism 4, 51. doi:10.1186/2040-2392-4-51
28. Südhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911. doi:10.1038/nature07456
29. Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., et al. (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76. doi:10.1126/science.1146221
30. Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., et al. (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488, 647–651. doi:10.1038/nature11310
31. Tyzio, R., Nardou, R., Ferrari, D. C., Tsintsadze, T., Shahrokhi, A., Eftekhari, S., et al. (2014). Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 343, 675–679. doi:10.1126/science.1247190